{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-071913","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.595888+00:00","generated_at":"2026-06-01T05:01:34.725610+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Shareholders elect directors with majority support; Nasdaq confirms audit committee compliance","bullets":["Peter Neupert elected with 69.15% for (30.85% withhold); Michelle Griffin with 82.93% for.","Advisory vote on 2023 executive compensation passed with 86% support.","Ratification of Ernst & Young as independent auditor for FY2024 passed with 99.6% approval.","Nasdaq confirmed compliance with Listing Rule 5605(c)(2) after Peter Neupert joined audit committee in July 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-071913","json":"https://secwatch.observer/filing/0000950170-24-071913.json","markdown":"https://secwatch.observer/filing/0000950170-24-071913.md","text":"https://secwatch.observer/filing/0000950170-24-071913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000095017024071913/0000950170-24-071913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000095017024071913/adpt-20240607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:01:34.725610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}